Use of TRPA1 antagonists to prevent or treat infections caused by biological-warfare agents

摘要

Provided are methods for preventing and treating injuries caused by exposure to biological warfare agents. The methods include administering to a subject in need thereof an effective amount of a TRPA1 antagonist or a pharmaceutically acceptable salt thereof. In an embodiment the TRPA1 antagonist is selected from the group consisting of compounds of formula I; and compounds of formula II; as described herein.